Outset Medical Inc (OM) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Outset Medical Inc   (NASDAQ: OM)
 

Outset Medical Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Outset Medical Inc 's inventory turnover ratio sequentially decreased to 1.39 in the first quarter 2026, unsurprisingly, as the Outset Medical Inc markets continue to deteriorate, and OM's faces growing challenges to bring down its inventories. Outset Medical Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 263 days, from 259 days, in the Dec 31 2025 quarter.

Within Healthcare sector 274 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 1403, from total ranking in the fourth quarter 2025 at 1519.

OM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Outset Medical Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OM Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth -10.97 % -19.83 % -19.77 % -15.18 % -0.12 %
Y / Y Cost of Sales Growth -16.67 % -14.29 % -5.56 % 11.76 % -5.26 %
Inventory Turnover Ratio (TTM) 1.39 1.41 1.38 1.33 1.24
OM's Total Ranking # 1403 # 1519 # 1519 # 1376 # 1249
Average inventory processing period 263 260 264 275 294
Seq. Inventory Growth 4.29 % -3.41 % -5.67 % -6.31 % -6.09 %
Seq. Cost of Sales Growth -16.67 % 5.88 % -10.53 % 5.56 % -14.29 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 126
Healthcare Sector # 275
Overall Market # 1403

Inventory Turnover Ratio Statistics
High Average Low
5.04 2.15 1.25
(Mar 31 2021)   (Mar 31 2025)



OM Company Profile >> Back to OM Efficiency Comparisons >> Compare OM Inventory Turnover Ratio to its Competitors

Financial Statements
Outset Medical Inc 's Inventories $ 50 Millions Visit OM's Balance sheet
Outset Medical Inc 's Cost of Revenues TTM $ 69 Millions Visit OM's Income Statement
What are OM's Sales? Visit OM's Sales by Segment

Other Inventory Turnover Ratios
Outset Medical Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
OM's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for OM's Competitors
Inventory Turnover Ratio for OM's Suppliers
Inventory Turnover Ratio for OM's Customers

You may also want to know
OM's Sales Growth Rates OM's Pe Price to earnings ratio OM's Receivables Turnover Ratio OM's Stock Quote
OM's Net Income Growth Rates OM's Ps Price to Sales ratio OM's Sales per Employee OM's Asset Turnover Ratio
OM's Net Margin OM's Pb Price to Book ratio OM's Financial Strength Ratios OM's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Escalon Medical Corp   3.79 $ 6.698  Millions$ 2  Millions
Evolus Inc   3.71 $ 103.000  Millions$ 28  Millions
Abbvie Inc   3.70 $ 18,420.000  Millions$ 4,975  Millions
Alpha Teknova Inc   3.69 $ 26.248  Millions$ 7  Millions
Biocryst Pharmaceuticals Inc   3.67 $ 19.884  Millions$ 5  Millions
Neuraxis Inc   3.61 $ 0.665  Millions$ 0  Millions
Mirum Pharmaceuticals Inc   3.50 $ 85.221  Millions$ 24  Millions
Tandem Diabetes Care Inc   3.45 $ 461.746  Millions$ 134  Millions
Exelixis Inc   3.41 $ 84.478  Millions$ 25  Millions
Baxter International Inc   3.37 $ 7,911.000  Millions$ 2,348  Millions
Gilead Sciences Inc   3.36 $ 6,139.000  Millions$ 1,825  Millions
Maravai Lifesciences Holdings Inc   3.33 $ 143.875  Millions$ 43  Millions
Intelligent Bio Solutions Inc   3.31 $ 2.064  Millions$ 1  Millions
Agilent Technologies inc   3.29 $ 3,418.000  Millions$ 1,038  Millions
Cadre Holdings inc   3.28 $ 372.000  Millions$ 113  Millions
Solventum Corporation  3.23 $ 3,363.000  Millions$ 1,042  Millions
Biofrontera Inc   3.22 $ 8.867  Millions$ 3  Millions
10x Genomics Inc   3.21 $ 193.000  Millions$ 60  Millions
Iovance Biotherapeutics inc   3.14 $ 165.941  Millions$ 53  Millions
Lftd Partners Inc   3.12 $ 28.258  Millions$ 9  Millions
Prestige Consumer Healthcare Inc   3.11 $ 493.000  Millions$ 159  Millions
Beyond Air Inc   3.07 $ 6.521  Millions$ 2  Millions
Bausch Health Companies Inc   3.07 $ 2,987.000  Millions$ 974  Millions
Indivior Pharmaceuticals Inc   3.03 $ 242.000  Millions$ 80  Millions
Amneal Pharmaceuticals Inc   3.02 $ 1,868.000  Millions$ 618  Millions
Logicmark Inc  3.01 $ 3.826  Millions$ 1  Millions
Mettler toledo International Inc   3.01 $ 1,189.678  Millions$ 395  Millions
Revvity Inc  3.00 $ 1,151.379  Millions$ 384  Millions
Cannapharmarx Inc   2.98 $ 2.921  Millions$ 1  Millions
Becton Dickinson And Company  2.97 $ 11,368.000  Millions$ 3,821  Millions

Date modified: 2026-08-29T17:42:03+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.